BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21855860)

  • 1. Dendritic cells transfected with PD-L1 recombinant adenovirus induces T cell suppression and long-term acceptance of allograft transplantation.
    Peng W; Ran B; Ma Y; Huang X; Chang Q; Wang X
    Cell Immunol; 2011; 271(1):73-7. PubMed ID: 21855860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCs sensitized with mPD-L1-Ig fusion protein improve the effect of heart transplantation in mice by promoting the generation of T-reg cells.
    Liu C; Chen H; Jia J; Hong T; Wang C
    Cell Immunol; 2014 Jul; 290(1):169-77. PubMed ID: 24997656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
    Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
    J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel pseudovirus containing lewis X oligosaccharides with pD-L1 targeting to DCs induces T cells tolerance.
    Wang X; Yang X; Cui S; Yan Y; Yang Z
    Transplantation; 2009 May; 87(9):1305-7. PubMed ID: 19424029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation.
    Liu L; Zheng Q; Lee J; Ma Z; Zhu Q; Wang Z
    J Cell Mol Med; 2015 Jun; 19(6):1223-33. PubMed ID: 25810125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
    Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
    Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
    Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
    Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of T cells suppression by dendritic cells transfected with VSIG4 recombinant adenovirus.
    Xu S; Sun Z; Li L; Liu J; He J; Song D; Shan G; Liu H; Wu X
    Immunol Lett; 2010 Jan; 128(1):46-50. PubMed ID: 19914289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble mouse B7-H3 down-regulates dendritic cell stimulatory capacity to allogenic T cell proliferation and production of IL-2 and IFN-gamma.
    Xu J; Huang B; Xiong P; Feng W; Xu Y; Fang M; Zheng F; Gong F
    Cell Mol Immunol; 2006 Jun; 3(3):235-40. PubMed ID: 16893505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromes.
    Liu Q; Lv Y; Zhao M; Jin Y; Lu J
    Int J Clin Exp Pathol; 2015; 8(2):1374-83. PubMed ID: 25973021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance.
    Li XL; Ménoret S; Bezie S; Caron L; Chabannes D; Hill M; Halary F; Angin M; Heslan M; Usal C; Liang L; Guillonneau C; Le Mauff B; Cuturi MC; Josien R; Anegon I
    J Immunol; 2010 Jul; 185(2):823-33. PubMed ID: 20543104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
    Wang L; Han R; Hancock WW
    Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
    Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
    Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.